Cargando…
Transcriptome profiling of five brain regions in a 6‐hydroxydopamine rat model of Parkinson’s disease
BACKGROUND: Parkinson's disease (PD) is a neurodegenerative disease, and its pathogenesis is unclear. Previous studies mainly focus on the lesions of substantia nigra (SN) and striatum (Str) in PD. However, lesions are not limited. The olfactory bulb (OB), subventricular zone (SVZ), and hippoca...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8504527/ https://www.ncbi.nlm.nih.gov/pubmed/34347369 http://dx.doi.org/10.1111/cns.13702 |
_version_ | 1784581336347967488 |
---|---|
author | Lyu, Ying Huang, Yiying Shi, Guiying Lei, Xuepei Li, Keya Zhou, Ran Bai, Lin Qin, Chuan |
author_facet | Lyu, Ying Huang, Yiying Shi, Guiying Lei, Xuepei Li, Keya Zhou, Ran Bai, Lin Qin, Chuan |
author_sort | Lyu, Ying |
collection | PubMed |
description | BACKGROUND: Parkinson's disease (PD) is a neurodegenerative disease, and its pathogenesis is unclear. Previous studies mainly focus on the lesions of substantia nigra (SN) and striatum (Str) in PD. However, lesions are not limited. The olfactory bulb (OB), subventricular zone (SVZ), and hippocampus (Hippo) are also affected in PD. AIM: To reveal gene expression changes in the five brain regions (OB, SVZ, Str, SN, and Hippo), and to look for potential candidate genes and pathways that may be correlated with the pathogenesis of PD. MATERIALS AND METHODS: We established control group and 6‐hydroxydopamine (6‐OHDA) PD model group, and detected gene expressions in the five brain regions using RNA‐seq and real‐time quantitative polymerase chain reaction (RT‐qPCR). We further analyzed the RNA‐seq data by bioinformatics. RESULTS: We identified differentially expressed genes (DEGs) in all five brain regions. The DEGs were significantly enriched in the “dopaminergic synapse” and “retrograde endocannabinoid signaling,” and Gi/o‐GIRK is the shared cascade in the two pathways. We further identified Ephx2, Fam111a, and Gng2 as the potential candidate genes in the pathogenesis of PD for further studies. CONCLUSION: Our study suggested that gene expressions change in the five brain regions following exposure to 6‐OHDA. The “dopaminergic synapse,” “retrograde endocannabinoid signaling,” and Gi/o‐GIRK may be the key pathways and cascade of the synaptic damage in 6‐OHDA PD rats. Ephx2, Fam111a, and Gng2 may play critical roles in the pathogenesis of PD. |
format | Online Article Text |
id | pubmed-8504527 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-85045272021-10-18 Transcriptome profiling of five brain regions in a 6‐hydroxydopamine rat model of Parkinson’s disease Lyu, Ying Huang, Yiying Shi, Guiying Lei, Xuepei Li, Keya Zhou, Ran Bai, Lin Qin, Chuan CNS Neurosci Ther Original Articles BACKGROUND: Parkinson's disease (PD) is a neurodegenerative disease, and its pathogenesis is unclear. Previous studies mainly focus on the lesions of substantia nigra (SN) and striatum (Str) in PD. However, lesions are not limited. The olfactory bulb (OB), subventricular zone (SVZ), and hippocampus (Hippo) are also affected in PD. AIM: To reveal gene expression changes in the five brain regions (OB, SVZ, Str, SN, and Hippo), and to look for potential candidate genes and pathways that may be correlated with the pathogenesis of PD. MATERIALS AND METHODS: We established control group and 6‐hydroxydopamine (6‐OHDA) PD model group, and detected gene expressions in the five brain regions using RNA‐seq and real‐time quantitative polymerase chain reaction (RT‐qPCR). We further analyzed the RNA‐seq data by bioinformatics. RESULTS: We identified differentially expressed genes (DEGs) in all five brain regions. The DEGs were significantly enriched in the “dopaminergic synapse” and “retrograde endocannabinoid signaling,” and Gi/o‐GIRK is the shared cascade in the two pathways. We further identified Ephx2, Fam111a, and Gng2 as the potential candidate genes in the pathogenesis of PD for further studies. CONCLUSION: Our study suggested that gene expressions change in the five brain regions following exposure to 6‐OHDA. The “dopaminergic synapse,” “retrograde endocannabinoid signaling,” and Gi/o‐GIRK may be the key pathways and cascade of the synaptic damage in 6‐OHDA PD rats. Ephx2, Fam111a, and Gng2 may play critical roles in the pathogenesis of PD. John Wiley and Sons Inc. 2021-08-04 /pmc/articles/PMC8504527/ /pubmed/34347369 http://dx.doi.org/10.1111/cns.13702 Text en © 2021 The Authors. CNS Neuroscience & Therapeutics Published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Articles Lyu, Ying Huang, Yiying Shi, Guiying Lei, Xuepei Li, Keya Zhou, Ran Bai, Lin Qin, Chuan Transcriptome profiling of five brain regions in a 6‐hydroxydopamine rat model of Parkinson’s disease |
title | Transcriptome profiling of five brain regions in a 6‐hydroxydopamine rat model of Parkinson’s disease |
title_full | Transcriptome profiling of five brain regions in a 6‐hydroxydopamine rat model of Parkinson’s disease |
title_fullStr | Transcriptome profiling of five brain regions in a 6‐hydroxydopamine rat model of Parkinson’s disease |
title_full_unstemmed | Transcriptome profiling of five brain regions in a 6‐hydroxydopamine rat model of Parkinson’s disease |
title_short | Transcriptome profiling of five brain regions in a 6‐hydroxydopamine rat model of Parkinson’s disease |
title_sort | transcriptome profiling of five brain regions in a 6‐hydroxydopamine rat model of parkinson’s disease |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8504527/ https://www.ncbi.nlm.nih.gov/pubmed/34347369 http://dx.doi.org/10.1111/cns.13702 |
work_keys_str_mv | AT lyuying transcriptomeprofilingoffivebrainregionsina6hydroxydopamineratmodelofparkinsonsdisease AT huangyiying transcriptomeprofilingoffivebrainregionsina6hydroxydopamineratmodelofparkinsonsdisease AT shiguiying transcriptomeprofilingoffivebrainregionsina6hydroxydopamineratmodelofparkinsonsdisease AT leixuepei transcriptomeprofilingoffivebrainregionsina6hydroxydopamineratmodelofparkinsonsdisease AT likeya transcriptomeprofilingoffivebrainregionsina6hydroxydopamineratmodelofparkinsonsdisease AT zhouran transcriptomeprofilingoffivebrainregionsina6hydroxydopamineratmodelofparkinsonsdisease AT bailin transcriptomeprofilingoffivebrainregionsina6hydroxydopamineratmodelofparkinsonsdisease AT qinchuan transcriptomeprofilingoffivebrainregionsina6hydroxydopamineratmodelofparkinsonsdisease |